Drugs / Fluoro-L-Thymidine
last change Feb 2013 re-read 3 minutes ago

Fluoro-L-Thymidine

Diagnostic / imaging agent

Investigated by
Columbia University · National Cancer Institute (NCI)

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT01065818 Aug 2009 → Feb 2013 esophageal cancer, non-small cell lung carcinoma Columbia University Terminated No outcome recorded Stop: Business

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Fluoro-L-Thymidine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01065818 ↗
Modality Diagnostic / imaging agent “4D-PET/CT imaging with an injection of Fluoro-L-Thymidine at pre-Neoadjuvant Therapy and post-3 weeks Neoadjuvant Therapy prior to surgery.” NCT01065818 ↗